BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20570907)

  • 1. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review.
    Wheless L; Black J; Alberg AJ
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1686-95. PubMed ID: 20570907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmelanoma skin cancer and risk for subsequent malignancy.
    Chen J; Ruczinski I; Jorgensen TJ; Yenokyan G; Yao Y; Alani R; Liégeois NJ; Hoffman SC; Hoffman-Bolton J; Strickland PT; Helzlsouer KJ; Alberg AJ
    J Natl Cancer Inst; 2008 Sep; 100(17):1215-22. PubMed ID: 18728282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
    Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
    Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
    JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers?
    Alberg AJ; Fischer AH
    Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):433-6. PubMed ID: 24609852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
    Troyanova P; Danon S; Ivanova T
    Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort.
    Eide MJ; Johnson DA; Jacobsen GR; Krajenta RJ; Rao DS; Lim HW; Johnson CC
    Arch Dermatol; 2011 Dec; 147(12):1379-84. PubMed ID: 21844426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohort Study of Nonmelanoma Skin Cancer and the Risk of Exfoliation Glaucoma.
    Kang JH; VoPham T; Laden F; Rosner BA; Wirostko B; Ritch R; Wiggs JL; Qureshi A; Nan H; Pasquale LR
    J Glaucoma; 2020 Jun; 29(6):448-455. PubMed ID: 32487970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
    Brewster AM; Alberg AJ; Strickland PT; Hoffman SC; Helzlsouer K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1271-5. PubMed ID: 15298945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I; Stern RS
    Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of non-melanocytic skin cancers in people with a history of skin cancer.
    Czarnecki D; Mar A; Staples M; Giles G; Meehan C
    Dermatology; 1994; 189(4):364-7. PubMed ID: 7873821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H; Li WQ; Qureshi AA; Han J
    J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nonmelanoma skin cancer with second malignancy.
    Rosenberg CA; Greenland P; Khandekar J; Loar A; Ascensao J; Lopez AM
    Cancer; 2004 Jan; 100(1):130-8. PubMed ID: 14692033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
    Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of developing subsequent nonmelanoma skin cancers.
    Veien K; Veien NK
    Arch Dermatol; 2001 Sep; 137(9):1251. PubMed ID: 11559232
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin cancer in organ transplant recipients: dynamics in the incidence and clinical predictors for the first and subsequent post-transplant non-melanoma skin cancer.
    Hartmann J; Schüler S; Enk AH; Lonsdorf AS
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1281-1289. PubMed ID: 30811675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.
    Perkins JL; Liu Y; Mitby PA; Neglia JP; Hammond S; Stovall M; Meadows AT; Hutchinson R; Dreyer ZE; Robison LL; Mertens AC
    J Clin Oncol; 2005 Jun; 23(16):3733-41. PubMed ID: 15923570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated detection of nonmelanoma skin cancer using digital images: a systematic review.
    Marka A; Carter JB; Toto E; Hassanpour S
    BMC Med Imaging; 2019 Feb; 19(1):21. PubMed ID: 30819133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
    Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.